LJ2011_prefinal_program_-_March_2011.pdf

Sunday, May 15th, 2011 6:00 – 9:00 pm Registration 7:00 pm - Welcome and opening reception Monday, May 16th, 2011 7:00 – 8:00 Registration and light breakfast 8:00 – 8.30 am Opening remarks Opening Special Lecture: Chair TBA Time Name and affiliation Title 8:30 – 9:15 am Aaron Ciechanover, Nobel Laureate Why our proteins have to die so we shall live, or the uniquitin proteolytic system – from basic mechanisms thru human diseases and onto drug development. Session 1: Applied Liposome Technology I Cancer Therapy. Dedicated to Demetrios Paphadjopoulos. Chairs: Gert Storm and Nahum Goldberg 9:15 – 9:30 Craig Henderson Doxil and beyond: clinical perspective. 9:30 – 9:45 am Alberto Gabizon Improved therapeutic index of a mitomycin-C pro- drug formulated in pegylated liposomes. 9:30 – 9:45 am Avi Schroder Programmed nano-robots for treating metastasis 9:45 – 10:15 am Refreshment break 10:15 – 10:30 am Philip Low Ligand-targeting of liposomes and low molecular weight drugs to cancer and sites of inflammation. 10:30 –10:45 am Danny Zucker Optimization of vincristine – topotecan combination - paving the way for improved chemotherapy regimens by nanoliposomes. 10:45 - 11:00 am Gabriel Lopez-Berestein Transporting nucleotides to the cancer microenvironment. 11:00 - 11:15 am Kazuo Maruyama Cancer immunotherapy utilized ultrasound sensitive liposomes (Bubble liposomes). 11:15 – 11:30 am Vladimir Torchilin Liposomes as drug carriers for intracellular targeting and multidrug resistance reversal. 11:30 – 11:45 pm Nahum Goldberg The synergy in cancer treatment between liposomal chemotherapeutics and thermal ablation by radiofrequency (RF). 11:45 – 12:00 pm Terry Allen Nanomedicines: where have we been; where are we going? 12:00 – 1:00 pm Workshop I: The role of liposomes in future cancer therapy. Moderators: Alberto Gabizon and Craig Henderson. Speakers (5 minutes ea